ArticleAIDS and behavior2026
HIV Pre-exposure Prophylaxis at a Local Public Health Department in the Southern United States: Reducing Barriers, Increasing Access, and Lessons Learned.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) is a key component of a comprehensive approach to ending the HIV pandemic. Still, uptake is low for individuals most likely to derive the greatest benefit, including underrepresented populations in the Southern United States (U.S). We initiated a rapid PrEP initiation program to increase PrEP uptake. We performed a retrospective study analyzing demographic, clinical characteristics, and rates of PrEP follow-up for individuals started on rapid PrEP at the Durham County Department of Public Health in Durham, North Carolina, U.S. We also evaluated what factors were associated with continuation of PrEP and subsequent PrEP follow-up. Overall, rates of PrEP continuation were low at 42% at 3 months. PrEP continuation was positively associated with follow-up at one of the academic medical centers in our area. Almost half of the individuals who failed to make their 3-month PrEP appointment were subsequently seen back in our Sexual Health Clinic, and these individuals were more likely to identify as female and lack health insurance. Overall, PrEP discontinuation rates were high at 3 months, likely in part due to high rates of individuals lacking health insurance in our setting. Half of the individuals who discontinued PrEP returned to our health department for sexual health services, suggesting that while offering PrEP at local health departments in the U.S. may be an important entry point for PrEP care, providing the full spectrum of PrEP care at local public health departments may improve retention on PrEP.
Indexed as
Identifiers
41708543What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.